Truist Financial Corp Sells 1,363 Shares of Genpact Limited (NYSE:G)

Truist Financial Corp trimmed its holdings in shares of Genpact Limited (NYSE:G – Get Rating) by 4.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 26,576 shares of the business services provider’s stock after selling 1,363 shares during the period. Truist Financial Corp’s holdings in Genpact were worth $1,164,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in G. Brown Brothers Harriman & Co. lifted its holdings in shares of Genpact by 25.9% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 1,021 shares of the business services provider’s stock worth $43,000 after acquiring an additional 210 shares during the period. CWM LLC lifted its holdings in shares of Genpact by 22.2% during the 2nd quarter. CWM LLC now owns 1,255 shares of the business services provider’s stock worth $53,000 after acquiring an additional 228 shares during the period. Castleview Partners LLC acquired a new stake in shares of Genpact during the 2nd quarter worth about $70,000. EverSource Wealth Advisors LLC increased its position in shares of Genpact by 1,456.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,583 shares of the business services provider’s stock worth $109,000 after purchasing an additional 2,417 shares in the last quarter. Finally, Captrust Financial Advisors increased its position in shares of Genpact by 179.9% during the 1st quarter. Captrust Financial Advisors now owns 2,774 shares of the business services provider’s stock worth $121,000 after purchasing an additional 1,783 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on G shares. JPMorgan Chase & Co. cut shares of Genpact from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $55.00 to $50.00 in a research report on Thursday, December 15th. Robert W. Baird dropped their target price on shares of Genpact from $56.00 to $54.00 in a research report on Thursday, November 10th. StockNews.com upgraded shares of Genpact from a “buy” rating to a “strong-buy” rating in a research report on Thursday. Citigroup lowered their price objective on shares of Genpact from $56.00 to $52.00 and set a “buy” rating for the company in a research report on Thursday, November 10th. Finally, BMO Capital Markets lowered their price objective on shares of Genpact from $57.00 to $51.00 and set a “market perform” rating for the company in a research report on Thursday, November 10th. Four research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of “Moderate Buy” and a consensus price target of $51.43.

Insider Buying and Selling at Genpact

In other news, CEO N. V. Tyagarajan sold 50,000 shares of Genpact stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $48.24, for a total value of $2,412,000.00. Following the sale, the chief executive officer now directly owns 644,377 shares in the company, valued at $31,084,746.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Darren Saumur sold 45,000 shares of Genpact stock in a transaction that occurred on Thursday, December 8th. The shares were sold at an average price of $45.09, for a total value of $2,029,050.00. Following the sale, the senior vice president now directly owns 95,684 shares in the company, valued at $4,314,391.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO N. V. Tyagarajan sold 50,000 shares of Genpact stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $48.24, for a total transaction of $2,412,000.00. Following the completion of the sale, the chief executive officer now owns 644,377 shares in the company, valued at $31,084,746.48. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 312,928 shares of company stock valued at $14,455,797. 2.67% of the stock is currently owned by corporate insiders.

Genpact Stock Up 0.1 %

Shares of NYSE:G opened at $47.00 on Friday. The company has a 50 day moving average of $45.57 and a 200-day moving average of $45.84. Genpact Limited has a one year low of $37.68 and a one year high of $51.97. The stock has a market cap of $8.61 billion, a price-to-earnings ratio of 26.40, a P/E/G ratio of 1.50 and a beta of 1.24. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.08 and a quick ratio of 1.08.

Genpact (NYSE:G – Get Rating) last released its quarterly earnings data on Wednesday, November 9th. The business services provider reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.07. Genpact had a net margin of 7.76% and a return on equity of 23.73%. The business had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.08 billion. On average, sell-side analysts forecast that Genpact Limited will post 2.42 earnings per share for the current year.

Genpact Company Profile

(Get Rating)

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).